Page last updated: 2024-09-04

olmesartan and Colitis Gravis

olmesartan has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdo, WS; El-Ahwany, E; Khalil, RM; Nassif, D; Saber, S	1

Other Studies

1 other study(ies) available for olmesartan and Colitis Gravis

Article	Year
Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk. Toxicology and applied pharmacology, 2019, 02-01, Volume: 364 Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Apoptosis; Apoptosis Regulatory Proteins; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Heme Oxygenase (Decyclizing); Imidazoles; Inflammation Mediators; Male; NF-E2-Related Factor 2; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Rats, Wistar; Signal Transduction; Tetrazoles; Transcription Factor RelA	2019

Article

Year

Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk.

Toxicology and applied pharmacology, 2019, 02-01, Volume: 364

Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Apoptosis; Apoptosis Regulatory Proteins; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Heme Oxygenase (Decyclizing); Imidazoles; Inflammation Mediators; Male; NF-E2-Related Factor 2; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Rats, Wistar; Signal Transduction; Tetrazoles; Transcription Factor RelA

2019